Clinical Study on Elderly COPD with Pulmonary Interstitial Fibrosis Treated by Bushenhuoxue
|School||Shandong University of Traditional Chinese Medicine|
|Course||Chinese medical science|
|Keywords||Elderly COPD Interstitial pulmonary fibrosis Bushenhuoxue Traditional Chinese medicine|
Objective : This paper aims from a theoretical and clinical aspects of elderly COPD with pulmonary interstitial fibrosis characteristics and Chinese medicine treatment for systematic observation and discussion , seeking elderly COPD with pulmonary interstitial fibrosis drug to explore traditional Chinese medicine on elderly COPD with pulmonary interstitial fibrosis improvement mechanism . Methods: The clinical study of 60 cases of elderly COPD patients with pulmonary fibrosis were randomly divided into two groups , were given oral Bushenhuoxue Decoction ( treatment group ) and TMP injection ( Green River ) ( control group ) treatment 3 months. Observed before and after treatment in patients with symptoms, signs and laboratory indicators of change . Results: Compared with the control group , the treatment group scores were significantly lower CRP (P lt; 0.05), changes in blood flow were significantly improved (P lt; 0.05), described Bushenhuoxue can significantly improve symptoms and signs . In improving imaging score and physiology score between the two groups before and after treatment between the two groups were not significantly different (P gt; 0.05). The treatment group before and after treatment IgA, IgG difference meaningless (P gt; 0.05), IgM increased after treatment (P lt; 0.05). The control group after treatment, IgG, IgA, IgM showed no significance. Two groups , IgG, IgA differences meaningless , IgM significant difference (P lt; 0.05), described BHF increased with increasing age can be reduced IgM, adjustment occurs with increasing age immunoglobulin changes to improve patients with immune function. Treatment and control groups before and after treatment T cell subsets were not significantly different . Conclusion : The disease is the vacuity total , Kidney Blood elderly COPD with pulmonary interstitial fibrosis major pathogenesis . Bushenhuoxue order significantly improve elderly COPD patients with pulmonary interstitial fibrosis symptoms and signs .